CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · IEX Real-Time Price · USD
2.180
-0.010 (-0.46%)
At close: Mar 28, 2024, 4:00 PM
2.050
-0.130 (-5.96%)
After-hours: Mar 28, 2024, 6:54 PM EDT

CytomX Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020201920182017201620152014
Market Capitalization
148104106283303378680811400752-
Market Cap Growth
--1.80%-62.58%-6.69%-19.81%-44.44%-16.18%102.67%-46.79%--
Enterprise Value
-14-58-71-67105243436217564-62
PE Ratio
-182.48-182.48-1.06-2.44-4.67-2.84-8.03-18.81-6.79-17.87-
PS Ratio
1.461.031.997.574.4314.0411.4211.3226.6097.49-
PB Ratio
-2.19-2.19-1.23-615.53-38.957.395.1911.605.105.96-
P/FCF Ratio
-1.83-1.83-0.94-2.34102.63-2.62-8.574.80-96.26-25.92-
P/OCF Ratio
-1.85-1.85-0.95-2.3757.57-2.69-9.004.76-196.88-27.42-
EV/Sales Ratio
-0.57-0.57-1.33-0.150.113.924.086.0814.4473.16-12.12
EV/EBITDA Ratio
-6.24-6.240.760.05-0.10-0.82-3.55-10.39-3.80-17.402.12
EV/EBIT Ratio
-17.34-17.340.710.05-0.09-0.79-3.45-9.99-3.69-16.782.06
EV/FCF Ratio
1.011.010.630.052.51-0.73-3.062.58-52.26-19.45-2.04
Debt / Equity Ratio
-0.29-0.29-0.21-39.34-2.790.49-----0.04
Debt / EBITDA Ratio
1.511.51-0.19-0.16-0.30-0.19-----0.10
Debt / FCF Ratio
-0.25-0.25-0.16-0.157.35-0.17----0.10
Quick Ratio
1.151.151.513.944.673.474.466.305.1811.975.95
Current Ratio
1.171.171.553.994.763.544.556.365.2612.065.99
Asset Turnover
0.470.470.200.100.170.070.140.220.080.06-
Interest Coverage
----------19.42-61.22
Return on Equity (ROE)
0.80%0.80%-666.30%-119.40%-153.50%-148.70%-89.20%-71.40%-61.70%-177.10%-
Return on Assets (ROA)
-0.30%-0.30%-38.00%-30.00%-16.50%-34.00%-20.00%-13.10%-29.80%-31.10%-
Return on Capital (ROIC)
-3.32%-3.32%149.70%-659.44%-579.38%-186.20%-59.50%-66.18%-75.93%-26.34%39.40%
Earnings Yield
-0.39%-0.55%-93.93%-41.01%-21.41%-35.18%-12.45%-5.32%-14.72%-5.60%-
FCF Yield
-38.52%-54.78%-106.42%-42.70%0.97%-38.13%-11.67%20.82%-1.04%-3.86%-
Buyback Yield / Dilution
-12.27%-12.27%-2.48%-39.01%-1.79%-8.81%-12.10%-2.57%-321.57%-768.69%-28.11%
Total Shareholder Return
-12.27%-12.27%-2.48%-39.01%-1.79%-8.81%-12.10%-2.57%-321.57%-768.69%-28.11%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).